日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

NAT10-mediated N4-acetylcytidine (ac4C) modification of PIK3R2 mRNA promotes malignant progression of glioblastoma.

NAT10 介导的 PIK3R2 mRNA 的 N4-乙酰胞苷 (ac4C) 修饰促进胶质母细胞瘤的恶性进展。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-08328-y
Meng Xiannan, Dong Tao, Xu Jiayu, Tian Kaiwen, Yang Wendong, Liu Zixuan, Qian Yongjing, Liu Dingding, Chen Changxiu, Bai Jin, Yong Hongmei, Wu Xiaojin, Shen Zhigang
细胞生物学
NAT10
发表日期：2025
文献求助 收藏

IL-6 is a prognostic biomarker in patients with advanced esophageal squamous cell carcinoma received with PD-1 inhibitors.

IL-6 是接受 PD-1 抑制剂治疗的晚期食管鳞状细胞癌患者的预后生物标志物

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1569042
Huang Ping, Zhao Manyi, Xia Jianhong, Li Hongliang, Sun Junxia, Li Xin, Yang Chunsheng, Gao Guangyi, Zhou Wenhang, Zhong Meifeng, Yong Hongmei
细胞生物学
IL-6
发表日期：2025
文献求助 收藏

PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression

PRMT5介导的ALKBH5甲基化通过增加CD276表达促进结直肠癌的免疫逃逸

期刊:
影响因子:
doi:10.34133/research.0549
Meng, Sen; Liu, Hao; Xu, Jiayu; Deng, Chuyin; Qian, Xingyou; Chu, Sufang; Zhu, Wei-Guo; Zhu, Jiuling; Yong, Hongmei; Li, Zhongwei; Bai, Jin
肠癌
ALK
免疫/内分泌
表观遗传
CD27
CD2
CD276
肿瘤
肿瘤免疫
DNA甲基化
发表日期：2025
文献求助 收藏

PRMT5-Mediated Arginine Methylation of ACSL4 Attenuates Its Stability and Suppresses Ferroptosis in Renal Cancer.

PRMT5 介导的 ACSL4 精氨酸甲基化减弱其稳定性并抑制肾癌中的铁死亡

期刊:Research (Wash D C)
影响因子:
doi:10.34133/research.0789
Zhang Meng, Liu Hao, Yin Rong, Xu Jiayu, Fan Siqi, Qian Xingyou, Cao Menghan, Li Shu, Zhang Ao, Chen Guodong, Yong Hongmei, Li Zhongwei, Bai Jin
表观遗传
DNA甲基化
铁死亡
发表日期：2025
文献求助 收藏

Correction: Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9

更正：长链非编码RNA SH3PXD2A-AS1通过与DHX9相互作用促进非小细胞肺癌细胞增殖并加速细胞周期进程。

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-023-01596-7
Zhou, Yeqing; Yong, Hongmei; Cui, WenJie; Chu, Sufang; Li, Minle; Li, Zhongwei; Bai, Jin; Zhang, Hao
肺癌
肿瘤
肿瘤免疫
DHX9
细胞生物学
发表日期：2023
文献求助 收藏

Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors

一项多中心、单臂、II期研究（CAP）评估了放射治疗联合脂质体伊立替康，随后进行卡瑞利珠单抗和抗血管生成治疗在晚期实体瘤中的疗效。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1133689
Shen, Jie; Yan, Jing; Du, Juan; Li, Xiaoqin; Wei, Jia; Liu, Qin; Yong, Hongmei; Wang, Xiaolu; Chang, Xiaofeng; Ding, Zhou; Sun, Wu; Liu, Chenxi; Zhu, Sihui; Guo, Jingyi; Li, Huajun; Liu, Ying; Zhang, Wulou; Liu, Zonghang; Li, Rutian; Liu, Baorui
血管生成
发表日期：2023
文献求助 收藏

miR-504 Promoted Gastric Cancer Cell Proliferation and Inhibited Cell Apoptosis by Targeting RBM4

miR-504通过靶向RBM4促进胃癌细胞增殖并抑制细胞凋亡

期刊:Journal of Immunology Research
影响因子:3.6
doi:10.1155/2021/5555950
Zhang, Yi; Yong, Hongmei; Fu, Jing; Gao, Guangyi; Shi, Huichang; Zhou, Xueyi; Fu, Mingsheng
胃癌
肿瘤
凋亡
表观遗传
肿瘤免疫
Apoptosis
细胞生物学
发表日期：2021
文献求助 收藏

Long Noncoding RNA MLK7-AS1 Promotes Non-Small-Cell Lung Cancer Migration and Invasion via the miR-375-3p/YWHAZ Axis

长链非编码RNA MLK7-AS1通过miR-375-3p/YWHAZ轴促进非小细胞肺癌的迁移和侵袭

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.626036
Jia, Jingzhou; Sun, Jiwei; Wang, Wenbo; Yong, Hongmei
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients

索拉非尼联合5-氟尿嘧啶化疗方案对晚期胃癌患者HIF-1α和VEGF表达及生存的影响

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2017.5769
Cheng, Ronghui; Yong, Hongmei; Xia, Yunhong; Xie, Qingsong; Gao, Guangyi; Zhou, Xueyi
胃癌
肿瘤
肿瘤免疫
EGF
VEGF
发表日期：2017
文献求助 收藏

Trop2 is overexpressed in gastric cancer and predicts poor prognosis

Trop2在胃癌中过度表达，预示着不良预后。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.6733
Zhao, Wei; Zhu, Huijun; Zhang, Shu; Yong, Hongmei; Wang, Wei; Zhou, Yan; Wang, Bing; Wen, Jinbo; Qiu, Zhenning; Ding, Guipeng; Feng, Zhenqing; Zhu, Jin
胃癌
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏